Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
03/17/2023* -- Results Q4 2022 -- -0.71 --
11/14/2022 -- Results Q3 2022 -- -0.45 --
08/10/2022 -- Results Q2 2022 -- -0.50 --
05/16/2022 -- Results Q1 2022 -- -0.47 --
03/17/2022 -- Results Q4 2021 -0.53 -0.47 -10.92%
11/09/2021 -- Results Q3 2021 -0.50 -0.44 -14.94%
08/10/2021 -- Results Q2 2021 -0.36 -0.42 14.29%
05/14/2021 -- Results Q1 2021 0.00 0.03 --
*Estimated Date/Time

Earnings

Next Report Date 03/17/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/14/2022
Beat/Miss Upgrade
Return Since -6.51%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
URL https://www.cullinanoncology.com
Investor Relations URL N/A
HQ State/Province Massachusetts
Sector Healthcare
Industry Biotechnology
Equity Style N/A
Next Earnings Release Mar. 17, 2023 (est.)
Last Earnings Release Nov. 14, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio --
Cash Payout Ratio --
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
--
--
--
--
--
--
-31.63%
11.56%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
7.86%
1.52%
32.62%
22.97%
-18.85%
-12.50%
39.23%
-23.19%
-3.40%
31.92%
-1.96%
-30.89%
28.47%
-14.43%
2.37%
6.26%
-7.99%
8.43%
-17.11%
-9.75%
51.14%
14.55%
50.71%
-64.28%
3.41%
4.68%
16.13%
25.06%
-6.73%
3.51%
66.74%
-10.42%
-13.22%
As of February 03, 2023.

Profile

Edit
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
URL https://www.cullinanoncology.com
Investor Relations URL N/A
HQ State/Province Massachusetts
Sector Healthcare
Industry Biotechnology
Equity Style N/A
Next Earnings Release Mar. 17, 2023 (est.)
Last Earnings Release Nov. 14, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

No data available
Symbol Dollars Invested % Weight
     
     
     
     
     
     
     
     
     
     

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter CGEM Tweets